Effects of phenylarsine oxide on agonist-induced hepatic vasoconstriction and glycogenolysis.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D001151:Arsenic / Q000633:toxicity; D001152:Arsenicals / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects*; D008112:Liver Glycogen / Q000378:metabolism*; D010477:Perfusion; D014661:Vasoconstriction / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D001152:Arsenicals; D008112:Liver Glycogen; C029341:oxophenylarsine; D001151:Arsenic